India's obesity treatment market is set to expand rapidly as local drugmakers prepare to release affordable versions of Novo Nordisk’s drug following patent expiration. The anticipated price drop could drive demand, prompting clinics and hospitals to enhance …
Indian firms including Ajanta Pharma, Dr. Reddy's Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals, are poised to fulfill demand for weight loss drugs with more affordable generic options … [+2790 chars]
